How many clinical trials are studying Leuprolide?

7 recruiting trials in our tracked data involve Leuprolide.

What conditions is Leuprolide being studied for?

In our tracked recruiting trials, Leuprolide is being studied in trials for Prostate Cancer, Breast cancer, Anatomic Stage I Breast Cancer AJCC v8.

Leuprolide: clinical trials recruiting now

Q: Is Leuprolide FDA-approved?

Yes. According to the FDA drug label available through openFDA, Leuprolide is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Leuprolide appears in the FDA drug-label database. Marketed as CAMCEVI.

FDA-approved use

CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer. CAMCEVI is a gonadotropin-releasing hormone (GnRH) agonist indicated for the treatment of adult patients with advanced prostate cancer.

FDA label via openFDA

Phase breakdown

Phase 2 5 Phase 3 2

Conditions being studied

Condition	Trials
Prostate Cancer · Leuprolide for Prostate Cancer	5
Breast cancer	2
Anatomic Stage I Breast Cancer AJCC v8	1
Anatomic Stage II Breast Cancer AJCC v8	1
Anatomic Stage III Breast Cancer AJCC v8	1
Anatomic Stage IV Breast Cancer AJCC v8	1
Biochemically Recurrent Prostate Carcinoma	1
Castration-resistant Prostate Cancer	1
Early Breast Cancer	1
Localized Prostate Carcinoma	1
Metastatic Breast Carcinoma	1
Prostate Adenocarcinoma	1
Prostatic Neoplasms	1
Recurrent Castration-Sensitive Prostate Carcinoma	1
Recurrent Prostate Cancer	1

Recruiting trials involving Leuprolide

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
NCT07455903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT06330805 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
NCT07158021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT05827081 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 229 locations
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
NCT06650579 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
NCT05765500 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
NCT06378866 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations

Common questions

Is Leuprolide FDA-approved?

Yes, marketed as CAMCEVI.

How many recruiting trials involve Leuprolide?

7 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.